Powered by the Strateos LodeStar software, large-scale private cloud labs are being designed and implemented globally
Strateos, a provider of lab automation software and remote access laboratories for life science research, announced a strategic shift aimed at meeting the growing demand from its life sciences customers seeking to establish on-site implementations of fully automated cloud labs that can be accessed from anywhere in the world. In line with this shift, Strateos is reorganising and expanding its business to focus on design-and-deployment engagements.
“As a pioneer in cloud labs, our mission remains clear: to digitise discovery and to free life scientists from having to manually manage workflows and perform all their work in a physical lab. Disrupting an established industry often requires the flexibility to pivot toward demand, which for biopharmaceutical customers is creating state-of-the-art on-site cloud labs,” said Mark Fischer-Colbrie, Strateos Chief Executive Officer. “The urgent need for transformation combined with the opportunity of artificial intelligence is driving demand for Strateos LodeStar software and our design and deployment capabilities. We are pleased to announce the recent completion of multimillion-dollar design programs with two top 20 biopharmaceutical companies to accelerate their digital transformation.”
At the centre of the Strateos technology offering are LodeStar, a scalable software platform enabling companies to manage their on-premises research operations and instruments to run scientific workflows via the cloud at enterprise scale while creating machine- and human-actionable data streams under FAIR data standards. During a LodeStar deployment, the Strateos implementation team brings unique expertise in scientific software and process development, automation, lab design, and operational knowledge established from its experience running fully integrated, LodeStar-powered cloud labs, which is distinct from other industry software and automation providers.
Customers using the Strateos LodeStar software gain new scientific capabilities that include: the remote control and automation of scientific devices, workflow design, scheduling, reagent resourcing, experiment execution, data generation, management of experimental requests, calendaring of workflows, and coordination of teams across geographies. The software also enables labs to approach their maximum capacity to continue growing and scaling without adding significant resources.
“As venture investors, we invest in deep tech solutions that change the world for the better and become high-growth, profitable companies,” said Jason Pontin, Chairman of Strateos’ Board of Directors and a Partner at DCVC. “By enabling biopharmaceutical companies to design and run fully automated, cloud-accessible labs, the Strateos team has found a practical way to do drug discovery faster, better, and less expensively.”
To support its strategic shift, the company previously announced the establishment of a Project Management Office to ensure the efficient and effective administration of all aspects of the deployment process, from initial assessment through design, implementation, and ongoing support. Strateos also recently underwent a reorganisation to adjust its staffing structure and is adding top-tier professionals who will design and deliver private cloud-enabled lab solutions. These strategies support the growing demand from the company’s customers seeking laboratory modernisation and transformation solutions.
